Concepedia

Publication | Closed Access

Preclinical Studies with JAA-F11 Anti-Thomsen-Friedenreich Monoclonal Antibody for Human Breast Cancer

27

Citations

27

References

2014

Year

Abstract

The results highlight the potential that humanized JAA-F11 may have for immunotherapy and drug conjugate therapy in breast cancer patients.

References

YearCitations

Page 1